CliniSpan Health brings diversification to clinical health trials
Chapel Hill-based startup CliniSpan Health is working to increase the presence of minorities in clinical health trials.
Read MorePosted by WRAL TechWire | May 7, 2021
Chapel Hill-based startup CliniSpan Health is working to increase the presence of minorities in clinical health trials.
Read MorePosted by Jason Parker | Apr 9, 2021
Rise Above COVID, a nationwide movement, partners with nearly 100 Black-owned barbershops and beauty salons in the Raleigh-Durham area to raise awareness and encourage enrollment in a clinical trial called ACTIV-2.
Read MorePosted by WRAL News | Oct 5, 2020
After testing positive for coronavirus, President Trump was treated with an antibody treatment similar to one currently in trials at Duke University.
Read MorePosted by WRAL News | Jul 29, 2020
RESEARCH TRIANGLE PARK, N.C. – For the second time in three days, the Trump administration focused its attention on coronavirus vaccine development work being done in North Carolina. Following in the footsteps of President Donald Trump, who toured a Morrisville plant on Monday where a vaccine candidate is being...
Read MorePosted by WRAL TechWire | Jul 17, 2019
The Research Triangle area, long known as a tech hub in addition to a growing life science presence, is also a leader in medical clinical trials, according to a new report from TrialScout. Here are the details.
Read MorePosted by WRAL News | Aug 31, 2018
Javara CEO wants to take the errors out of clinical trials by significantly improving patient enrollment.
Read MorePosted by Shannon Cuthrell | Jul 5, 2018
Pattern Health’s adherence platform can help more than improve individual care. Its tech has also shown use for researchers by helping eliminate the critical costs that can arise in trial studies.
Read MorePosted by WRAL TechWire | Mar 16, 2018
Worldwide Clinical Trials, which touts itself as “the cure for the common CRO,” is growing.
Read MorePosted by WRAL TechWire | Feb 2, 2018
SignalPath, a company that specializes in making software for clinical drug trials. has raised $8 million from investors.
Read More